Julie Maltzman

Julie Maltzman currently serves as Chief Medical Officer at Adicet Bio, Inc. since January 2025, following a role as Chief Medical Officer at IconOVir Bio from September 2022 to January 2025. Previous experience includes significant positions at Genentech, where Julie held the titles of VP Global Head of GI and Cancer Immunotherapy and Group Medical Director for Cancer Immunotherapy from 2018 to November 2022. Additional roles encompassed senior director at Gilead Sciences and Senior Director of Oncology Clinical Development at Morphotek Inc. Julie's expertise in oncology was also honed during tenure as Director at GSK and as an Instructor in Oncology at the University of Pennsylvania. Educational background includes a Doctor of Medicine from the University of Colorado Anschutz Medical Campus, an Internal Medicine residency at the University of Chicago, and a BA in Political Science from the University of Colorado Boulder. Julie completed a medical oncology fellowship at the University of Pennsylvania.